pain control after arthroscopy surgery. Z09.0:Follow-up examination after surgery for other conditions?Y45.9: Analgesic, antipyretic and anti-inflammatory drug, unspecified
Conditions
Interventions
Intervention 1: In Control group 150 mg of ropivacain soluted in salin 0.9% will be infused inta-articularly by arthroscope at the end of arthroscopy surgery. Intervention 2: In treatment group combin
Treatment - Drugs
In Control group 150 mg of ropivacain soluted in salin 0.9% will be infused inta-articularly by arthroscope at the end of arthroscopy surgery
In treatment group combination of 30 mg ketorolacand 150 mg ropivacain soluted in salin 0.9% will be infused inta-articularly by arthroscope at the end of arthroscopy surgery
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 60 Years
Inclusion criteria
Inclusion criteria: Intrance criteria: to be pleased with participating in this study, the ages between 15 to 60 years old, to have knee arthroscopy surgery under general anesthesia Exit criteria: the history of using analgesics 24 hours before surgery, the history of bleeding or coagulation problems during the last month before surgery, renal and liver failure, severe cardiopulmonary, coagulopathy, morbid obesity (BMI<30 kg/m2), the history of nausea and vomiting after surgery, the history of migraine, the history of problems incidence during and after surgery, incidence of problems 24 hours after surgery which need the interference, known allergy, sensivity and contraindication about the use of opioid and non-opioid analgesics, pregnancy and lactation, the history of drug and alcohol abuse, being not to satisfied for participating in this study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: after entrance to recovery room and 2, 4, 8, 12, 18, 24 hours after surgery. Method of measurement: according to VAS (Visual Analog Scale), 0:no pain, 1-3:slight, 4-7:moderate, 8-10:sever. | — |
Secondary
| Measure | Time frame |
|---|---|
| Nausea, vomiting and sedation. Timepoint: after entrance to recovery room and 2, 4, 8, 12, 18, 24 hours after surgery. Method of measurement: according to nausea and vomiting scale by patient's explaining about his/her symptoms (no nausea and vomiting/nausea/one to two order of nausea and vomiting/ nausea and vomiting more than two orders) - according to Ramsay sedation scale (1:Anxious or restless or both, 2:Cooperative, orientated and tranquil, 3:Responding to commands, 4:Brisk response to stimulus, 5:Sluggish response to stimulus, 6:No response to stimulus). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Masoomshahi
Tehran University of Medical Sciences
Outcome results
None listed